Verastem reported $-16962000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
AstraZeneca AZN:LN -347M 1305M
Cytokinetics CYTK:US $ -89.44M 58.88M
Immunogen IMGN:US $ -24.14M 13.03M
Novartis NOVN:VX SF 16308M 13550M
Tg Therapeutics TGTX:US $ -93.34M 7.7M
Verastem VSTM:US $ -16.96M 5.82M
Ziopharm Oncology ZIOP:US $ -9.79M 2.01M